Pharmacokinetics and bioavailability of ondansetron hydrochloride tablets in healthy volunteers
Qian Wang
Abstract
Qian Wang
Abstract
Objective To establish an HPLC method for determining the content of ondansetron hydrochloride,and discuss the bioavailability of it with the reference preparation of ondansetron hydrochloride tablets.Methods 20 healthy volunteers were administered with 8 mg of test preparation or reference preparation randomly.The plasma concentration was determined by RP-HPLC method,to study the pharmacokinetics and relative bioavailability.Results The pharmacokinetic parameters of test and reference preparations were as follows:Cmax:(48.21±0.34)and(46.30±18.77)ng/mL;AUC0-t:(203.48±56.80)and(206.03±53.60)ng · h/mL;AUC0-∞:(223.24±55.74)and(227.14±55.59)ng · h/mL;t1/2:(4.39±1.75)and(4.22±1.27)h.The relative bioavailability of test preparation was 101.1%±0.2%.Conclusion The two preparations were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To establish an HPLC method for determining the content of ondansetron hydrochloride,and discuss the bioavailability of it with the reference preparation of ondansetron hydrochloride tablets.Methods 20 healthy volunteers were administered with 8 mg of test preparation or reference preparation randomly.The plasma concentration was determined by RP-HPLC method,to study the pharmacokinetics and relative bioavailability.Results The pharmacokinetic parameters of test and reference preparations were as follows:Cmax:(48.21±0.34)and(46.30±18.77)ng/mL;AUC0-t:(203.48±56.80)and(206.03±53.60)ng · h/mL;AUC0-∞:(223.24±55.74)and(227.14±55.59)ng · h/mL;t1/2:(4.39±1.75)and(4.22±1.27)h.The relative bioavailability of test preparation was 101.1%±0.2%.Conclusion The two preparations were bioequivalent.
Key concepts: Bioavailability, Bioequivalence, Cmax, Pharmacokinetics, Ondansetron, Pharmacology, High-performance liquid chromatography, Chromatography